BioSpace News Archive

Pharm Country

DepYmed to Meet with Investors at the Life Sciences Summit in New York City October 11, 2023

DepYmed, Inc. (“DepYmed” or the “Company”) is a preclinical stage pharmaceutical company focused on developing transformative treatments for rare diseases and oncology that target the protein tyrosine phosphatase (PTP) family of enzymes.

October 3, 2023
·
2 min read
Pharm Country

EQUASHIELD’S SYRINGE UNIT FDA CLEARED FOR FULL-VOLUME USE

EQUASHIELD®, a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, is thrilled to announce that its EQUASHIELD® Syringe Unit has received FDA clearance for full-volume use:

October 3, 2023
·
3 min read
BioMidwest

New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers

New physician guidelines now recommend use of contrast-enhanced ultrasound (CEUS) to diagnose hepatocellular carcinoma (HCC), the most common primary liver cancer.

October 3, 2023
·
3 min read
Business

Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Specialty cancer diagnostics company Precipio, Inc., announces that the combination of revenue growth and cost cutting initiatives has reduced Cash Burn From Operations by 59% compared to the same quarter last year, from approximately $2.5M/quarter to $1M/quarter.

October 3, 2023
·
4 min read
BioMidwest

GenomOncology Welcomes Garreth Hippe as Chief Commercial Officer

GenomOncology, a prominent precision oncology software company, announced the appointment of Garreth Hippe as Chief Commercial Officer.

October 3, 2023
·
2 min read
Business

COVETRUS® AND VETCOR® EXPAND STRATEGIC PARTNERSHIP WITH MULTI-YEAR AGREEMENT

Covetrus®, a global leader in animal-health technology and services, today announced the signing of a multi-year strategic alignment with Vetcor®, a community-centric veterinary services company.

October 3, 2023
·
2 min read
Business

Aperio Continues Growth with Appointment of Eric Ross as Chief Commercial Officer

Aperio Clinical Outcomes, a prominent data focused clinical research organization, appoints Eric Ross as Chief Commercial Officer, as the company adds additional infrastructure to support continued growth.

October 3, 2023
·
2 min read
Genetown

Merck Helps To Improve Diversity in Clinical Trials Through Beacon of Hope

Increasing diversity in clinical trials plays a crucial role in helping to understand how a broad range of human bodies may respond to treatments.

October 3, 2023
·
2 min read
Deals

Cadence Announces the Acquisition of ARC Group Worldwide’s Florida Location

Cadence, Inc. announced that it has acquired the Florida location of ARC Group Worldwide, a precision manufacturer specializing in Metal Injection Molding and cleanroom plastic injection molding.

October 3, 2023
·
3 min read
Business

Saghmos Therapeutics Announces Appointment of Pharmaceutical Industry Veteran Fred Hassan as Chairman of the Board of Directors

Saghmos Therapeutics, Inc., a privately held biopharmaceutical company, developing the cardiorenal metabolic modulator ST-62516, announces the appointment of Fred Hassan as Chairman of the Board of Directors.

October 3, 2023
·
5 min read